Literature DB >> 13868186

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

H BERNHEIMER, W BIRKMAYER, O HORNYKIEWICZ.   

Abstract

Entities:  

Keywords:  BRAIN/metabolism; PARALYSIS AGITANS/metabolism; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13868186     DOI: 10.1007/BF01487648

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  16 in total

1.  Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.

Authors:  R KUNTZMAN; P A SHORE; D BOGDANSKI; B B BRODIE
Journal:  J Neurochem       Date:  1961-02       Impact factor: 5.372

2.  Distribution of catechol compounds in human brain.

Authors:  I SANO; T GAMO; Y KAKIMOTO; K TANIGUCHI; M TAKESADA; K NISHINUMA
Journal:  Biochim Biophys Acta       Date:  1959-04

3.  Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

Authors:  M HOLZBAUER; M VOGT
Journal:  J Neurochem       Date:  1956-05       Impact factor: 5.372

4.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

5.  Serotonin as a mediator of reserpine action in brain.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1956-01       Impact factor: 4.030

6.  Serotonin content of some mammalian tissues and urine and a method for its determination.

Authors:  B M TWAROG; I H PAGE
Journal:  Am J Physiol       Date:  1953-10

7.  [Effect of pyridoxin in diseases of the central nervous system].

Authors:  W BIRKMAYER; S SCHMID
Journal:  Klin Med Osterr Z Wiss Prakt Med       Date:  1950-09

8.  Tremor in cats: the effect of administration of drugs into the cerebral ventricles.

Authors:  F R Domer; W Feldberg
Journal:  Br J Pharmacol Chemother       Date:  1960-12

9.  Studies on the 5-hydroxytryptamine (serotonin) content in human brain.

Authors:  E COSTA; M H APRISON
Journal:  J Nerv Ment Dis       Date:  1958-03       Impact factor: 2.254

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  48 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  [THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

Authors:  W UMBACH; D BAUMANN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

3.  TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.

Authors:  K JENSEN; A AMDISEN
Journal:  Psychopharmacologia       Date:  1964-03-11

4.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

5.  [AUTONOMIC REGULATION DISTURBANCES IN PATIENTS RECOVERING FROM ENCEPHALITIS].

Authors:  W BIRKMAYER
Journal:  Acta Neuroveg (Wien)       Date:  1964-10-02

6.  [ELECTROENCEPHALOGRAMS DURING ADMINISTRATION OF L-DOPA BEFORE, IN (DEPTH LEADS AND STIMULATION EFFECTS) AND AFTER STEREOTACTIC BRAIN OPERATIONS IN PARKINSON PATIENTS].

Authors:  H E DIEMATH; F HEPPNER; S ENGE; H LECHNER
Journal:  Acta Neuroveg (Wien)       Date:  1964-12-17

7.  [Experiences with stereotactic surgery. IV. Onthe long-term effect of bilateral pallidotomy in Parkinson's syndrome].

Authors:  H ORTHNER; F ROEDER
Journal:  Acta Neurochir (Wien)       Date:  1962-12-12       Impact factor: 2.216

8.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

9.  In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.

Authors:  W Wesemann; G Dette-Wildenhahn; H Fellehner
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

10.  EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.

Authors:  J Vardi; H Glaubman; J Rabey; M Streifler
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.